October 2019 - Volume 29 - Issue 8 - Contributor Index

Alphabetical Search
A
D
H
N
P
Q
U
V
X
Z
Author:
Barman, Poulami

Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer

Ingle, James N.; Kalari, Krishna R.; Momozawa, Yukihide; More

Pharmacogenetics and Genomics. 29(8):183-191, October 2019.

Author:
Cairns, Junmei

Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer

Ingle, James N.; Kalari, Krishna R.; Momozawa, Yukihide; More

Pharmacogenetics and Genomics. 29(8):183-191, October 2019.

Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer

Ingle, James N.; Kalari, Krishna R.; Momozawa, Yukihide; More

Pharmacogenetics and Genomics. 29(8):183-191, October 2019.

Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer

Ingle, James N.; Kalari, Krishna R.; Momozawa, Yukihide; More

Pharmacogenetics and Genomics. 29(8):183-191, October 2019.

Author:
Chung, Jee Eun

Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer

Ingle, James N.; Kalari, Krishna R.; Momozawa, Yukihide; More

Pharmacogenetics and Genomics. 29(8):183-191, October 2019.

Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system

Fohner, Alison E.; Ranatunga, Dilrini K.; Thai, Khanh K.; More

Pharmacogenetics and Genomics. 29(8):192-199, October 2019.

Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer

Ingle, James N.; Kalari, Krishna R.; Momozawa, Yukihide; More

Pharmacogenetics and Genomics. 29(8):183-191, October 2019.

Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer

Ingle, James N.; Kalari, Krishna R.; Momozawa, Yukihide; More

Pharmacogenetics and Genomics. 29(8):183-191, October 2019.

Author:
Goss, Paul E.

Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer

Ingle, James N.; Kalari, Krishna R.; Momozawa, Yukihide; More

Pharmacogenetics and Genomics. 29(8):183-191, October 2019.

Author:
Gwak, Hye Sun
Author:
Ingle, James N.

Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer

Ingle, James N.; Kalari, Krishna R.; Momozawa, Yukihide; More

Pharmacogenetics and Genomics. 29(8):183-191, October 2019.

Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system

Fohner, Alison E.; Ranatunga, Dilrini K.; Thai, Khanh K.; More

Pharmacogenetics and Genomics. 29(8):192-199, October 2019.

Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer

Ingle, James N.; Kalari, Krishna R.; Momozawa, Yukihide; More

Pharmacogenetics and Genomics. 29(8):183-191, October 2019.

Author:
Kim, Woorim
Author:
Kubo, Michiaki

Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer

Ingle, James N.; Kalari, Krishna R.; Momozawa, Yukihide; More

Pharmacogenetics and Genomics. 29(8):183-191, October 2019.

Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system

Fohner, Alison E.; Ranatunga, Dilrini K.; Thai, Khanh K.; More

Pharmacogenetics and Genomics. 29(8):192-199, October 2019.

Author:
Lee, Kyung Eun
Author:
Liu, Vincent X.

Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system

Fohner, Alison E.; Ranatunga, Dilrini K.; Thai, Khanh K.; More

Pharmacogenetics and Genomics. 29(8):192-199, October 2019.

Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer

Ingle, James N.; Kalari, Krishna R.; Momozawa, Yukihide; More

Pharmacogenetics and Genomics. 29(8):183-191, October 2019.

Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system

Fohner, Alison E.; Ranatunga, Dilrini K.; Thai, Khanh K.; More

Pharmacogenetics and Genomics. 29(8):192-199, October 2019.

Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system

Fohner, Alison E.; Ranatunga, Dilrini K.; Thai, Khanh K.; More

Pharmacogenetics and Genomics. 29(8):192-199, October 2019.

Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system

Fohner, Alison E.; Ranatunga, Dilrini K.; Thai, Khanh K.; More

Pharmacogenetics and Genomics. 29(8):192-199, October 2019.

Author:
Risch, Neil

Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system

Fohner, Alison E.; Ranatunga, Dilrini K.; Thai, Khanh K.; More

Pharmacogenetics and Genomics. 29(8):192-199, October 2019.

Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system

Fohner, Alison E.; Ranatunga, Dilrini K.; Thai, Khanh K.; More

Pharmacogenetics and Genomics. 29(8):192-199, October 2019.

Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer

Ingle, James N.; Kalari, Krishna R.; Momozawa, Yukihide; More

Pharmacogenetics and Genomics. 29(8):183-191, October 2019.

Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer

Ingle, James N.; Kalari, Krishna R.; Momozawa, Yukihide; More

Pharmacogenetics and Genomics. 29(8):183-191, October 2019.

Author:
Tang, Xiaojia

Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer

Ingle, James N.; Kalari, Krishna R.; Momozawa, Yukihide; More

Pharmacogenetics and Genomics. 29(8):183-191, October 2019.

Author:
Thai, Khanh K.

Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system

Fohner, Alison E.; Ranatunga, Dilrini K.; Thai, Khanh K.; More

Pharmacogenetics and Genomics. 29(8):192-199, October 2019.

Author:
Wang, Liewei

Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer

Ingle, James N.; Kalari, Krishna R.; Momozawa, Yukihide; More

Pharmacogenetics and Genomics. 29(8):183-191, October 2019.

Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer

Ingle, James N.; Kalari, Krishna R.; Momozawa, Yukihide; More

Pharmacogenetics and Genomics. 29(8):183-191, October 2019.

Author:
Yee, Jeong
Show: